Thyroxine-binding globulin inhibitors

DBCAT004603Pharmacologic class

Drugs that decrease the level of TBG in the plasma. A DrugBank category of 38 drugs. 35 of them are approved.

What you can answer from here — as of December 09, 2019

38DrugsEach linked to its full drug card
Sign in
30Drug targetsEvery drug–target pair in the class, with bond type
Sign in
8,984Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
39Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Thyroxine-binding globulin inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.

Create Account